LOADING
On February 17, 2026, the Department of Veterans Affairs published an interim final rule in the Federal Register titled "Evaluative Rating: Impact of Medication." The rule proposed a fundamental shift in how the VA evaluates disability conditions for rating purposes. Under this new framework, VA raters would have been permitted to consider how a veteran's condition presents while the veteran is taking medication - meaning that if medication successfully reduced symptoms, the VA could assign a lower disability rating based on the medicated state rather than the underlying severity of the condition. The implications of this change were enormous, and the veteran community responded with immediate and overwhelming opposition.
To understand why this rule was so controversial, you need to understand the long-standing principle it attempted to overturn. For decades, VA policy and federal case law have established that disability ratings should reflect the severity of the underlying condition, not how well medication controls the symptoms. The logic is straightforward: if a veteran takes medication daily to manage a condition, the condition itself has not improved - the veteran is simply managing it through ongoing treatment. Remove the medication, and the full severity of the condition returns. Rating a veteran based on the medicated state would be like saying a diabetic veteran who takes insulin is no longer diabetic because their blood sugar is controlled.
The key legal precedent on this issue is Ingram v. Collins, decided in 2025. In that case, the court ruled explicitly that the VA must rate conditions as they present without the ameliorative effects of medication. The court found that the VA's schedule for rating disabilities is designed to assess the underlying severity of a condition, and that factoring in medication effectiveness would unfairly penalize veterans who comply with their treatment plans. This ruling reinforced what many veterans and advocates had long argued: that rating conditions in their medicated state creates a perverse incentive for veterans to stop taking their medications in order to maintain their ratings.
The backlash to the February 17 rule was swift and massive. Within the first 48 hours of publication, thousands of comments began flooding the Federal Register. By the time the dust settled, nearly 20,000 comments had been submitted - an extraordinary number for a VA rulemaking action. The overwhelming majority of these comments opposed the rule. Veterans, family members, Veterans Service Organizations, medical professionals, legal advocates, and members of Congress all raised objections.
Major VSOs including the Veterans of Foreign Wars (VFW), Disabled American Veterans (DAV), the American Legion, and Paralyzed Veterans of America issued public statements opposing the rule. Their arguments were consistent: the rule would punish veterans for following medical advice, would create an incentive to refuse treatment, and would undermine the trust veterans place in the VA system. Several VSOs noted that the rule could disproportionately affect veterans with mental health conditions, where medication management is often critical to daily functioning.
The political pressure was equally intense. Members of Congress from both parties publicly criticized the rule. The Senate Veterans' Affairs Committee and the House Veterans' Affairs Committee both signaled their opposition. The concern was bipartisan: reducing ratings based on medication compliance was seen as fundamentally unfair to the people who had earned those benefits through their service.
VA Secretary Doug Collins responded to the backlash by halting enforcement of the rule within days of its publication. On February 27, 2026 - just ten days after the rule was published - the VA formally rescinded it. In the rescission notice, the VA acknowledged the concerns raised by the veteran community and stated that the rule would not be enforced or implemented. The rescission was effective immediately, and the VA confirmed that no veterans had been adversely affected by the rule during the brief window it was technically in effect.
For veterans who are currently rated for conditions managed by medication, this reversal means your ratings are secure. The VA cannot reduce your rating simply because your medication is working. The Ingram v. Collins precedent remains the controlling legal standard: your condition must be evaluated based on its underlying severity, not its medicated presentation. Whether you take medication for PTSD, hypertension, diabetes, epilepsy, depression, or any other service-connected condition, the VA must rate you based on how the condition would present without that medication.
This episode also illustrates an important point about VA rulemaking and the power of veteran advocacy. The speed of the reversal was nearly unprecedented. The VA typically takes months or years to finalize or rescind proposed rules, but the scale of the opposition - nearly 20,000 comments in days - combined with the clear legal precedent from Ingram v. Collins made the VA's position untenable. Veterans who submitted comments, contacted their representatives, and raised awareness on social media played a direct role in getting this rule reversed.
Going forward, veterans should remain vigilant about proposed rule changes that could affect their benefits. The Federal Register is the official publication where all proposed and final VA rules appear, and public comment periods are the primary mechanism for veterans to make their voices heard. VSOs monitor these developments closely and often organize comment campaigns when harmful rules are proposed. Staying connected with a VSO and following VA policy news are the best ways to ensure you are informed about potential changes before they take effect.
If you are concerned about whether any of your current ratings have been affected by medication considerations, you can review your rating decision letters, which detail the rationale the VA used to assign your rating. If you believe a past rating decision improperly factored in medication effectiveness, you may have grounds for a supplemental claim or higher level review. The Claim Recon Decision Decoder tool can help you interpret your rating decision letter and identify potential errors.
Disclaimer: This article is for educational and informational purposes only. It does not constitute legal, medical, or VA claims advice. VA regulations and policies are subject to change. Always verify current eligibility requirements at VA.gov or consult with an accredited VSO, attorney, or claims agent before making decisions about your benefits.
Written by Claim Recon Editorial